THEDACARE MEDICAL CENTER-NEW LONDON — History
CCN 521326 | 3-year financial timeline | COVID resilience: 60/100
🛡️ Public data only — no PHI permitted on this instance.
$38M
Latest Revenue (FY2022)
+3.8%
Revenue CAGR (3yr)
9.2%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $35M | $38M | $38M | -0.8% | +3.8% |
| Operating Expenses | $33M | $33M | $34M | +2.8% | +2.0% |
| Operating Margin | 5.9% | 12.4% | 9.2% | -25.7% | +25.1% |
| Net Income | $2M | $5M | $3M | -26.3% | +29.9% |
| Licensed Beds | 25 | 25 | 25 | +0.0% | +0.0% |
| Total Patient Days | 3,079 | 2,402 | 2,945 | +22.6% | -2.2% |
| Medicare Day % | 31% | 30% | 24% | -18.0% | -12.0% |
| Medicaid Day % | 1% | 3% | 6% | +134.5% | +195.7% |
COVID Impact & Recovery
Resilience Score: 60/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +7.8% ($35M → $38M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+3.8%
This Hospital
+7.6%
State Avg
Latest Margin
9.2%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $39M | 10.9% |
| FY2024 (proj) | $40M | 12.6% |
| FY2025 (proj) | $42M | 14.2% |